Cargando…

Understanding gene-environment interactions in a mouse model of Crohn’s disease

Detalles Bibliográficos
Autor principal:	Duckworth, Carrie A.
Formato:	Texto
Lenguaje:	English
Publicado:	The Company of Biologists Limited 2011
Materias:	Journal Club
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3014340/ https://www.ncbi.nlm.nih.gov/pubmed/21183481 http://dx.doi.org/10.1242/dmm.007120

Ejemplares similares

Understanding soft sweeps: a signature of rapid adaptation
por: Garud, Nandita R.
Publicado: (2023)

Bridging Psychology and Mathematics: Can the Brain Understand the Brain?
por: Sigman, Mariano
Publicado: (2004)

Migrating Cells Dispose of Damaged Mitochondria into the Surrounding Environment: Mitochondria quality control coupled with cell migration in mammalian in vivo model
por: Lee, Choong-Sil, et al.
Publicado: (2021)

Chronic traumatic encephalopathy: identifying those at risk and understanding pathogenesis
por: Willis, M. D., et al.
Publicado: (2017)

Contribution of multi-modal imaging to our understanding of dystonia pathogenesis
por: MacIver, Claire, et al.
Publicado: (2021)

Vascular homeostasis: insights from a fibrotic mouse
por: Santoro, Stephen P., et al.
Publicado: (2011)

Transplantation of reprogrammed embryonic stem cells improves visual function in a mouse model for Retinitis Pigmentosa: Transplantation 2010 April 27;89 (8): 911-919
por: Sharma, Neel Kamal
Publicado: (2010)

A NOD to zebrafish models of inflammatory bowel disease pathogenesis
por: Allen, Irving C.
Publicado: (2011)

Maple syrup urine disease: new insights from a zebrafish model
por: Roberts, Nathan B.
Publicado: (2012)

Neural Networks of the Mouse Neocortex Cell. 2014 Feb 27;156(5):1096-111.
por: Tyagi, Rahul
Publicado: (2015)

Model Fitting Versus Curve Fitting: A Model of Renormalization Provides a Better Account of Age Aftereffects Than a Model of Local Repulsion
por: O’Neil, Sean F., et al.
Publicado: (2015)

Generation of retinal ganglion-like cells from reprogrammed mouse fibroblasts: IOVS 2010; 51(11): 5970–5978
por: Jindal, Neeru
Publicado: (2011)

Treatments in Alzheimer’s disease
por: Malik, G. A., et al.
Publicado: (2017)

Disease-modifying treatments in Alzheimer’s disease
por: Edwards, Marc, et al.
Publicado: (2023)

Interaction between IP(3) receptors and BK channels in arterial smooth muscle: non-canonical IP(3) signaling at work
por: Mujica, Patricio E., et al.
Publicado: (2011)

Tumour Suppressor Genes—One Hit Can Be Enough
por: Hohenstein, Peter
Publicado: (2004)

Genetics of disease severity in multiple sclerosis, Alzheimer’s disease, and Huntington’s disease: rejuvenating genome-wide association studies
por: Hrastelj, James, et al.
Publicado: (2017)

Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical disease
por: Willis, M. D., et al.
Publicado: (2018)

Insights on cannabidiol's antiallodynic and anxiolytic mechanisms of action in a model of neuropathic pain
por: Schott, Marion
Publicado: (2019)

Pathological looping in the synucleinopathies: investigating the link between Parkinson’s disease and Gaucher disease
por: Kinghorn, Kerri J.
Publicado: (2011)

Gene expression profiling of experimental saccular aneurysms using deoxyribonucleic acid microarrays
por: Kumar, Munish
Publicado: (2014)

Modelling how initiating and transforming oncogenes cooperate to produce a leukaemic cell state
por: Richardson, Simon E.
Publicado: (2013)

Selection of suitable housekeeping genes for expression analysis in glioblastoma using quantitative RT-PCR
por: Mathur, Deepali
Publicado: (2014)

New treatments in Alzheimer’s disease
por: Pickrell, William O., et al.
Publicado: (2018)

Sleep disorders in Parkinson’s disease
por: Hawken, Jonathan, et al.
Publicado: (2022)

The economic burden of chronic neurological disease
por: Wynford-Thomas, R., et al.
Publicado: (2017)

Repurposing drugs to treat neurological diseases
por: Massey, T. H., et al.
Publicado: (2018)

The gut microbiome: neurological development and disease
por: Miah, Latif, et al.
Publicado: (2022)

Soluble Guanylate Cyclase a1–Deficient Mice: a novel murine model for Primary Open Angle Glaucoma
por: Modgil, Shweta
Publicado: (2013)

Preclinical retinal neurodegeneration in a model of multiple sclerosis: The Journal of Neuroscience 2012; 32(16):5585–5597
por: Mathur, Deepali, et al.
Publicado: (2012)

Seizures in Alzheimer’s disease: is there more beneath the surface?
por: Edwards, Marc, et al.
Publicado: (2017)

New ways of looking at an old disease: the reimagination of epilepsy
por: Mitchell, Clinton J., et al.
Publicado: (2016)

Stem cells in the treatment of central nervous system disease
por: McLauchlan, Duncan, et al.
Publicado: (2018)

Creutzfeldt–Jacob disease: new directions in diagnosis and therapeutics
por: Al-Ansari, Aseel, et al.
Publicado: (2017)

Multiple sclerosis: early indicators of disease and assessing future risk
por: Willis, M. D., et al.
Publicado: (2020)

Beta-lactam antibiotic offers neuroprotection in a spinal muscular atrophy model by multiple mechanisms: Experimental Neurology 2011; 229: 214–225
por: Bhatia, Sonu
Publicado: (2011)

Cellular Senescence: The Villain of Metabolic Disease?: Discovery of a distinct senescent cell population in obesity-induced metabolic dysfunction
por: Lee, Gung
Publicado: (2022)

Parkin’ control: regulation of PGC-1α through PARIS in Parkinson’s disease
por: Castillo-Quan, Jorge Iván
Publicado: (2011)

Data Speak How to Treat Disease: Big data-based precision medicine
por: Hwang, Daehee
Publicado: (2022)

Robust real-world evidence: optimising disease-modifying treatments for multiple sclerosis
por: McArthur, C., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u2utcoeslqmtqdvjmhmcei32k2